Resolution of severe dilated cardiomyopathy with significant arrhythmia burden using hydroquinidine, in addition to guideline-directed medical therapy, in a patient with a pathogenic &lt;i&gt;SCN5A&lt;/i&gt; variant: a case report. The gene discussed is SCN5A; the disease is dilated cardiomyopathy.